Israeli oral COVID-19 vaccine en route to clinical trials

Unlike the Pfizer or Moderna vaccines that use messenger RNA, this is an oral subunit vaccine, meaning the vaccine presents the antigen to the immune system without introducing pathogen particles.

Israeli researchers at MigVax, who are working on an oral COVID-19 vaccine.

Israeli researchers at MigVax, who are working on an oral COVID-19 vaccine.

(photo credit: MIGAL RESEARCH INSTITUTE)

ByMAAYAN JAFFE-HOFFMAN

JUNE 11, 2021 06:26

Updated: JUNE 11, 2021 06:27